162 related articles for article (PubMed ID: 12711022)
1. Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate.
Raobaikady B; Purohit A; Chander SK; Woo LW; Leese MP; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):351-8. PubMed ID: 12711022
[TBL] [Abstract][Full Text] [Related]
2. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates.
Woo LL; Purohit A; Malini B; Reed MJ; Potter BV
Chem Biol; 2000 Oct; 7(10):773-91. PubMed ID: 11033081
[TBL] [Abstract][Full Text] [Related]
3. Steroid sulphatase inhibitors for breast cancer therapy.
Purohit A; Woo LW; Chander SK; Newman SP; Ireson C; Ho Y; Grasso A; Leese MP; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):423-32. PubMed ID: 14623540
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents.
Ireson CR; Chander SK; Purohit A; Perera S; Newman SP; Parish D; Leese MP; Smith AC; Potter BV; Reed MJ
Br J Cancer; 2004 Feb; 90(4):932-7. PubMed ID: 14970876
[TBL] [Abstract][Full Text] [Related]
5. In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate.
Purohit A; Williams GJ; Roberts CJ; Potter BV; Reed MJ
Int J Cancer; 1995 Sep; 63(1):106-11. PubMed ID: 7558436
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition of multi-drug-resistant breast cancer cells by 2-methoxyoestradiol-bis-sulphamate and 2-ethyloestradiol-bis-sulphamate.
Suzuki RN; Newman SP; Purohit A; Leese MP; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):269-78. PubMed ID: 12711013
[TBL] [Abstract][Full Text] [Related]
7. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV
J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207
[TBL] [Abstract][Full Text] [Related]
8. The effects of 2-methoxyoestrogen sulphamates on the in vitro and in vivo proliferation of breast cancer cells.
Utsumi T; Leese MP; Chander SK; Gaukroger K; Purohit A; Newman SP; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):219-27. PubMed ID: 15862969
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the development of steroid sulphatase inhibitors.
Purohit A; Hejaz HA; Woo LW; van Strien AE; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 1999; 69(1-6):227-38. PubMed ID: 10418996
[TBL] [Abstract][Full Text] [Related]
10. The role of steroid sulphatase in regulating the oestrogenicity of oestrogen sulphamates.
Chander SK; Purohit A; Woo LW; Potter BV; Reed MJ
Biochem Biophys Res Commun; 2004 Sep; 322(1):217-22. PubMed ID: 15313194
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of steroid sulphatase activity by tricyclic coumarin sulphamates.
Malini B; Purohit A; Ganeshapillai D; Woo LW; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2000 Dec; 75(4-5):253-8. PubMed ID: 11282279
[TBL] [Abstract][Full Text] [Related]
12. The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity.
Purohit A; Vernon KA; Hummelinck AE; Woo LW; Hejaz HA; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 1998 Mar; 64(5-6):269-75. PubMed ID: 9618028
[TBL] [Abstract][Full Text] [Related]
13. A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models.
Ishida H; Nakata T; Suzuki M; Shiotsu Y; Tanaka H; Sato N; Terasaki Y; Takebayashi M; Anazawa H; Murakata C; Li PK; Kuwabara T; Akinaga S
Breast Cancer Res Treat; 2007 Dec; 106(2):215-27. PubMed ID: 17268815
[TBL] [Abstract][Full Text] [Related]
14. In vivo activity of 4-methylcoumarin-7-O-sulfamate, a nonsteroidal, nonestrogenic steroid sulfatase inhibitor.
Purohit A; Woo LW; Singh A; Winterborn CJ; Potter BV; Reed MJ
Cancer Res; 1996 Nov; 56(21):4950-5. PubMed ID: 8895749
[TBL] [Abstract][Full Text] [Related]
15. 2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitor.
Reed JE; Woo LW; Robinson JJ; Leblond B; Leese MP; Purohit A; Reed MJ; Potter BV
Biochem Biophys Res Commun; 2004 Apr; 317(1):169-75. PubMed ID: 15047163
[TBL] [Abstract][Full Text] [Related]
16. The effects of 2-methoxy oestrogens and their sulphamoylated derivatives in conjunction with TNF-alpha on endothelial and fibroblast cell growth, morphology and apoptosis.
Ho YT; Newman SP; Purohit A; Leese MP; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2003 Aug; 86(2):189-96. PubMed ID: 14568571
[TBL] [Abstract][Full Text] [Related]
17. 2-MeOE2bisMATE induces caspase-dependent apoptosis in CAL51 breast cancer cells and overcomes resistance to TRAIL via cooperative activation of caspases.
Wood L; Leese MP; Mouzakiti A; Purohit A; Potter BV; Reed MJ; Packham G
Apoptosis; 2004 May; 9(3):323-32. PubMed ID: 15258464
[TBL] [Abstract][Full Text] [Related]
18. In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol.
Chander SK; Foster PA; Leese MP; Newman SP; Potter BV; Purohit A; Reed MJ
Br J Cancer; 2007 May; 96(9):1368-76. PubMed ID: 17426705
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo models for the evaluation of new inhibitors of human steroid sulfatase, devoid of residual estrogenic activity.
Shields-Botella J; Bonnet P; Duc I; Duranti E; Meschi S; Cardinali S; Prouheze P; Chaigneau AM; Duranti V; Gribaudo S; Rivière A; Mengual L; Carniato D; Cecchet L; Lafay J; Rondot B; Sandri J; Pascal JC; Delansorne R
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):327-35. PubMed ID: 12711019
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of MDA-MB-231 cell cycle progression and cell proliferation by C-2-substituted oestradiol mono- and bis-3-O-sulphamates.
Raobaikady B; Reed MJ; Leese MP; Potter BV; Purohit A
Int J Cancer; 2005 Oct; 117(1):150-9. PubMed ID: 15880363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
